Swiss - Delayed Quote CHF
Straumann Holding AG (STMN.SW)
104.95
-2.60
(-2.42%)
At close: June 13 at 5:31:20 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 20 | 20 |
Avg. Estimate | 0 | 0 | 3.46 | 3.97 |
Low Estimate | 0 | 0 | 3.14 | 3.52 |
High Estimate | 0 | 0 | 3.7 | 4.42 |
Year Ago EPS | -- | -- | 3.13 | 3.46 |
Revenue Estimate
Currency in CHF | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 19 | 20 |
Avg. Estimate | 685.3M | 610.6M | 2.7B | 2.97B |
Low Estimate | 685.3M | 610.6M | 2.62B | 2.78B |
High Estimate | 685.3M | 610.6M | 2.96B | 3.37B |
Year Ago Sales | 674.5M | 585.5M | 2.5B | 2.7B |
Sales Growth (year/est) | 1.60% | 4.29% | 7.76% | 10.05% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 3.46 | 3.97 |
7 Days Ago | 0 | 0 | 3.46 | 3.98 |
30 Days Ago | 0 | 0 | 3.47 | 3.99 |
60 Days Ago | 0 | 0 | 3.56 | 4.08 |
90 Days Ago | 0 | 0 | 3.59 | 4.12 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | 1 | 1 |
Down Last 30 Days | -- | -- | 5 | 5 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
STMN.SW | -- | -- | 10.69% | 14.62% |
S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Related Tickers
ALC.SW Alcon Inc.
70.90
-2.34%
TECN.SW Tecan Group AG
165.90
-3.27%
SKAN.SW SKAN Group AG
74.00
-0.40%
YPSN.SW Ypsomed Holding AG
407.00
-1.21%
ALCz.XC
6699.HK Angelalign Technology Inc.
57.650
-1.71%
AFX.DE Carl Zeiss Meditec AG
61.10
-0.81%
COLO-B.CO Coloplast A/S
637.00
-0.34%
IUI1.F Intuitive Surgical, Inc.
442.15
+0.03%
DIM.PA Sartorius Stedim Biotech S.A.
199.05
-1.95%